Vincent Giguère Selected Research

Diethylnitrosamine (N-Nitrosodiethylamine)

10/2013

Loss of estrogen-related receptor α promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent Giguère Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 09/2006
21	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2002
10	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 03/2012
5	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2011
4	Inflammation (Inflammations) 10/2021 - 11/2005
4	Carcinogenesis 01/2019 - 12/2010
3	Insulin Resistance 01/2022 - 02/2008
3	Non-alcoholic Fatty Liver Disease 10/2021 - 04/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2019
2	Body Weight (Weight, Body) 01/2018 - 11/2003
2	Osteoporosis 06/2017 - 11/2009
2	Cardiomegaly (Heart Hypertrophy) 02/2008 - 07/2007
2	Heart Failure 07/2007 - 07/2007
1	Liver Diseases (Liver Disease) 10/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021
1	Alcoholic Fatty Liver 10/2021
1	Fibrosis (Cirrhosis) 10/2021
1	Colitis 01/2021
1	Triple Negative Breast Neoplasms 10/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Septic Shock (Toxic Shock Syndrome) 07/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2014
1	Hepatocellular Carcinoma (Hepatoma) 10/2013
1	Hyperlipidemias (Hyperlipidemia) 04/2013
1	Metabolic Diseases (Metabolic Disease) 08/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2011
1	Tuberculosis (Tuberculoses) 06/2011
1	Infections 06/2011

Drug/Important Bio-Agent (IBA)

10	ERRalpha Estrogen-Related ReceptorIBA 01/2021 - 11/2003
8	Estrogens (Estrogen)FDA Link 01/2018 - 07/2002
6	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2022 - 06/2005
6	AndrogensIBA 01/2022 - 03/2012
6	Estrogen Receptor alphaIBA 08/2009 - 07/2002
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 09/2006
5	Orphan Nuclear ReceptorsIBA 01/2018 - 07/2005
4	ChromatinIBA 01/2022 - 06/2005
4	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 07/2005
4	Hormones (Hormone)IBA 01/2020 - 09/2006
4	Androgen Receptors (Androgen Receptor)IBA 01/2017 - 03/2012
3	EnzymesIBA 01/2022 - 12/2013
3	Triglycerides (Triacylglycerol)IBA 10/2021 - 01/2018
3	LipidsIBA 10/2021 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2021 - 12/2014
3	Estrogen ReceptorsIBA 04/2014 - 06/2005
3	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2014 - 06/2005
2	Insulin (Novolin)FDA Link 01/2022 - 02/2008
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
2	MethyltransferasesIBA 10/2020 - 01/2018
2	RetinoidsIBA 01/2014 - 01/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2006 - 07/2005
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	IsomerasesIBA 01/2022
1	Methionine (L-Methionine)FDA Link 10/2021
1	Biological ProductsIBA 10/2021
1	Choline (Choline Chloride)IBA 10/2021
1	Phenformin (Fenformin)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Buthionine SulfoximineIBA 01/2021
1	AnthracyclinesIBA 01/2021
1	Epirubicin (Ellence)FDA LinkGeneric 01/2021
1	BiguanidesIBA 01/2021
1	GSK5182IBA 01/2020
1	AntioxidantsIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Histone MethyltransferasesIBA 01/2019
1	CSK Tyrosine-Protein KinaseIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	fibroblast growth factor 21IBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2018
1	Citric Acid (Citrate)FDA LinkGeneric 01/2018
1	Histones (Histone)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 12/2016
1	Lapatinib (GW572016)FDA Link 12/2016
1	CarbonIBA 02/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2016
1	Methotrexate (Mexate)FDA LinkGeneric 02/2016
1	AMP-Activated Protein KinasesIBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2015
1	EndotoxinsIBA 07/2015
1	Trastuzumab (Herceptin)FDA Link 12/2014
1	Monoclonal AntibodiesIBA 12/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2014
1	Glutamine (L-Glutamine)FDA Link 12/2013
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 10/2013
1	CarcinogensIBA 10/2013
1	CateninsIBA 07/2013
1	Sirolimus (Rapamycin)FDA Link 04/2013
1	Oncogene Proteins (Oncogene Protein)IBA 01/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2012
1	Protein Tyrosine PhosphatasesIBA 03/2012
1	Nuclear Export Signals (Nuclear Export Signal)IBA 08/2011
1	Protein Isoforms (Isoforms)IBA 08/2011
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 08/2011
1	SERPIN-B5 (maspin)IBA 08/2011

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2013
2	Castration 01/2017 - 01/2017
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Ovariectomy (Oophorectomy) 06/2017